相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy
Fabiano de Oliveira Poswar et al.
HEART AND VESSELS (2019)
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system
Douglas dos Santos Soares et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2019)
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice
Esteban Alberto Gonzalez et al.
LIFE SCIENCES (2018)
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB
Valeria De Pasquale et al.
CELL DEATH & DISEASE (2018)
G-Protein-Coupled Receptors in Heart Disease
Jialu Wang et al.
CIRCULATION RESEARCH (2018)
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology
Mark J. Osborn et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I
Esteban Alberto Gonzalez et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity
Guilherme Baldo et al.
CARDIOVASCULAR PATHOLOGY (2017)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Defining a new diagnostic assessment parameter for wound care: Elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment
Thomas E. Serena et al.
WOUND REPAIR AND REGENERATION (2016)
An Update of the Role of Renin Angiotensin in Cardiovascular Homeostasis
Ehab Farag et al.
ANESTHESIA AND ANALGESIA (2015)
Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications
Yinan Hua et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
GPCR signaling and cardiac function
Leany A. Capote et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Myocardial Extracellular Matrix An Ever-Changing and Diverse Entity
Marieke Rienks et al.
CIRCULATION RESEARCH (2014)
Glycosaminoglycan metabolism defects and atherosclerosis: frequent association of endothelial dysfunction in patients with Mucopolysaccharidosis
Shoji Yano et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Mast Cells Are Key Mediators of Cathelicidin-Initiated Skin Inflammation in Rosacea
Yumiko Muto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Stain-Free technology as a normalization tool in Western blot analysis
Anne Guertler et al.
ANALYTICAL BIOCHEMISTRY (2013)
The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade
Paul W. Bigg et al.
MOLECULAR GENETICS AND METABOLISM (2013)
An old method facing a new challenge: Re-visiting housekeeping proteins as internal reference control for neuroscience research
Rena Li et al.
LIFE SCIENCES (2013)
Comparison of Stain-Free gels with traditional immunoblot loading control methodology
Alex D. Colella et al.
ANALYTICAL BIOCHEMISTRY (2012)
Role of various proteases in cardiac remodeling and progression of heart failure
Alison L. Mueller et al.
HEART FAILURE REVIEWS (2012)
Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats
Katherine P. Ponder et al.
MOLECULAR THERAPY (2012)
Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies
Nathan J. Palpant et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth
Izhak Kehat et al.
CIRCULATION RESEARCH (2011)
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
Elizabeth A. Braunlin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation
Guilherme Baldo et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Lessons on the pathogenesis of aneurysm from heritable conditions
Mark E. Lindsay et al.
NATURE (2011)
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Izhak Kehat et al.
CIRCULATION (2010)
Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment
Roberto Giugliani et al.
GENETICS AND MOLECULAR BIOLOGY (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Involvement of the Toll-like receptor 4 pathway and use of TNF-α antagonists for treatment of the mucopolysaccharidoses
Calogera M. Simonaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI
M. M. Sleeper et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice
Xiucui Ma et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo
Nicole H. Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy
Anne M. Traas et al.
MOLECULAR THERAPY (2007)
The MPS I registry: Design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I
Gregory M. Pastores et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The fuzzy logic of physiological cardiac hypertrophy
Gerald W. Dorn
HYPERTENSION (2007)
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Ichiro Shiojima et al.
GENES & DEVELOPMENT (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Akt1 is required for physiological cardiac growth
B DeBosch et al.
CIRCULATION (2006)
Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: Implications for assessment of therapeutic interventions in Hurler syndrome
E Braunlin et al.
PEDIATRIC RESEARCH (2006)
Cardiac manifestations in the mouse model of mucopolysaccharidosis I
MC Jordan et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure
R Kacimi et al.
HYPERTENSION (2003)
分享论文
